1616O Nab-paclitaxel plus gemcitabine versus modified FOLFIRINOX or S-IROX in metastatic or recurrent pancreatic cancer (JCOG1611, GENERATE): A multicentred, randomized, open-label, three-arm, phase II/III trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

1616O Nab-paclitaxel plus gemcitabine versus modified FOLFIRINOX or S-IROX in metastatic or recurrent pancreatic cancer (JCOG1611, GENERATE): A multicentred, randomized, open-label, three-arm, phase II/III trial

Published:2023-10 Issue: Volume:34 Page:S894
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ohba A.,Ozaka M.,Ogawa G.,Okusaka T.,Kobayashi S.,Yamashita T.,Ikeda M.,Yasuda I.,Sugimori K.,Sasahira N.,Ikezawa K.,Miki I.,Okano N.,Mizuno N.,Furukawa M.,Shirakawa H.,Sano Y.,Katayama H.,Furuse J.,Ueno M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Therapy for Metastatic Pancreatic Cancer—Current Landscape and Future Directions;Current Oncology;2024-09-04

2. Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study;European Journal of Cancer;2024-09

3. NALIRIFOX en première ligne de traitement de l’adénocarcinome pancréatique métastatique;Bulletin du Cancer;2024-09

4. Clinical efficacy and safety of irreversible electroporation combined with chemotherapy in stage IV pancreatic cancer treatment;Journal of Cancer Research and Therapeutics;2024-08

5. Head‐to‐head comparison of treatment sequences in advanced pancreatic cancer—Real‐world data from the prospective German TPK clinical cohort study;International Journal of Cancer;2024-07-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP